![Lori Macomber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lori Macomber
Director of Finance/CFO at KARYOPHARM THERAPEUTICS INC.
Net worth: 45 975 $ as of 29/06/2025
Profile
Lori Macomber currently works at Karyopharm Therapeutics, Inc., as Chief Financial Officer, Treasurer & Executive VP from 2025.
Ms. Macomber also formerly worked at AMETEK, Inc., as Business Unit Controller from 2018 to 2019, Eli Lilly & Co., as Assistant VP-Finance Site Leader from 2010 to 2017, Cello Health Ltd., as Controller & Chief Financial Officer-US Region from 2017 to 2018, and Legend Biotech Corp., as Chief Financial Officer from 2022 to 2025.
Ms. Macomber received her undergraduate degree from The Pennsylvania State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/01/2025 | 10,667 ( 0.13% ) | 45 975 $ | 29/06/2025 |
Latest news about Lori Macomber
Lori Macomber active positions
| Companies | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director of Finance/CFO | 02/01/2025 |
Former positions of Lori Macomber
| Companies | Position | End |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Director of Finance/CFO | 01/01/2025 |
| AMETEK, INC. | Corporate Officer/Principal | 31/08/2019 |
| CELLO HEALTH PLC | Comptroller/Controller/Auditor | 31/01/2018 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 31/03/2017 |
Training of Lori Macomber
The Pennsylvania State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| AMETEK, INC. | Producer Manufacturing |
| ELI LILLY AND COMPANY | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Cello Health Ltd.
 Cello Health Ltd. Miscellaneous Commercial ServicesCommercial Services Cello Health Plc provides strategic marketing services. It operates through two segments: Cello Health and Cello signal. The Cello Health segment provides market research, consulting, and communications services principally to its pharmaceutical and healthcare clients and Signal segment provides market research and direct communications services principally to its consumer facing clients. The company was founded by Mark Coleridge Scott and Kevin Barrie Steeds on May 5, 2004 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Lori Macomber
